Market Overview

Global Artificial Kidney Market is expected to register a CAGR of 95.54% during the forecast period from 2019 to 2025 and expected to reach USD 2,795.01 Million by 2025.

An artificial kidney is a portable medical device that allows individuals to experience the assistance of dialysis anywhere and anytime. In the past decade, there has been increasing research and development activities to enhance the dialysis process. Also, there has been an increasing demand for minimally invasive procedures to perform dialysis. An artificial kidney reduces the number of hospital visits to perform dialysis.

The market for the artificial kidney is expected to boost at a tremendous rate. Major factors influencing the growth of the market include increasing research and development, growing incidence of kidney disease, low availability of kidney donors, and increasing demand for technologically advanced devices among others.  

Factors such as engineering problems associated with the devices, immobile, and large size of the artificial kidney have been major challenges for the artificial kidney market.  

Market Drivers

• Increasing research and development to enhance the dialysis process
  
  
  
  • AWAK Technologies, a Singapore-based company, is involved in the development of the portable artificial kidney. In December 2019, the company upstretched USD 40 million to endure the development of its wearable peritoneal dialysis device. The device has received a breakthrough designation from the FDA
  
  
  • In September 2019, the US Kidney Research Corporation developed a new technology for purifying the blood of patients with end-stage renal disease (ESRD). This technology can be used to develop miniaturized implantable artificial kidney and a wearable artificial kidney. The technology can provide real-time data
  
  
  
  


• Growing number of kidney disease
  
  
  
  • According to a research study, it was found that about more than 660,000 people annually in the United States and accounted for 89,000 deaths
  
  
  • Each year two million individual across the globe are treated for end-stage renal disease (ESRD)
  
  
  
  


• Low availability of kidney donor
  
  
  
  • Annually in the US, out of the 100,000 people on the transplant waiting list, only 20,000 receive a donor's kidney
  
  
  
  

Artificial Kidney Market Challenges

• The current size of the artificial kidney is large and immobile

• Engineering problems associated with the devices

Research Methodology

Artificial Kidney Market Segmentation

By Type

• Wearable Artificial Kidney: Currently, wearable artificial kidney accounted for 100% of the market share for global artificial kidney market as implantable artificial devices are under clinical trials

• Implantable Artificial Kidney: These devices are under clinical trial and have been expected to receive FDA approval before the end of the forecast period. There are ongoing clinical trials on humans. If approved by the FDA, the segment is expected to grow at the fastest CAGR   

By Dialysis

• Hemodialysis: Accounted for the major market share owing to a large number of hemodialysis procedures. In the United States annually, more than 60% of all prevalent ESRD cases opt for hemodialysis therapy. Also, in Europe, more than 80% of the patients received hemodialysis each year.

• Peritoneal dialysis: is projected to be the second-largest market. Currently, there are three devices under development for peritoneal dialysis namely Automated Wearable Artificial Kidney Peritoneal Dialysis System (AWAK PD) by AWAK Technologies Pte. Ltd, Vicenza Wearable Artificial Kidney (ViWAK PD) by International Renal Research Institute of Vicenza/IRRIV, San Bortolo Hospital, and Carry Life Renal (Trimmed AB)

Artificial Kidney Market By Region

• Americas: The Americas spearheaded the market in 2018 and is likely to continue to command during the forecast period. This is attributed to the presence of a large number of medical device companies, increasing research and development by various public and private organizations, and the presence of a large number of the patient population with respect to kidney disease

• Europe: The region is projected to be the second-largest share owing to the increasing utilization of technologically advanced devices, increasing demand for minimally invasive procedures, raising the standards for chronic kidney disease treatment and among others. According to a research study, in Europe, the prevalence of stage 3 to 5 chronic kidney disease (CKD) in some adult populations is more than 22%.

• Asia-Pacific: This region is anticipated to grow at the fastest rate. This is attributed to the large target population in countries like China, India, and others. Annually, in India, more than 100,000 new patients have been diagnosed with End-Stage Kidney Disease who are on dialysis or transplantation

Key Development

In August 2018, The American Association of Kidney Patients (AAKP), one of the oldest and largest, fully independent kidney patient organizations, declared plans to join patient research efforts for The Kidney Project. The kidney project is an initiative for the development of a free-standing bioartificial kidney to treat End-Stage Renal Disease (ESRD).

Artificial Kidney Market Key Players

• Kawasumi Laboratories, Inc


• Blood Purification Technologies Inc.


• AWAK Technologies Pte. Ltd


• Triomed AB.


• Asahi Kasei Medical Vo., Ltd

Report Scope:

Report Attribute/Metric	Details
Market Size	USD 2,795.01 Million
CAGR	95.54% (2020-2027)
Base Year	2019
Forecast Period	2020-2027
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Type and Dialysis
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Kawasumi Laboratories, Inc. (Japan), Blood Purification Technologies Inc., AWAK Technologies Pte.Ltd.(Singapore), Triomed AB. (Sweden), Asahi Kasei Medical Vo., Ltd, and others.
Key Market Opportunities	Increasing demand for technologically advanced devices
Key Market Drivers	Increasing research and development to enhance the dialysis process Growing number of kidney disease Low availability of kidney donor

Frequently Asked Questions (FAQ) :

---